# Direct Endomyocardial Injection of Autologous Bone Marrow Cells to Treat Ischaemic Heart Failure

> **NCT01150175** · PHASE2 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 90 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Endomyocardial Injection of Autologous Bone Marrow Cells
- **PROCEDURE:** Endomyocardial Injection of Plasma

## Key facts

- **NCT ID:** NCT01150175
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2010-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150175, "Direct Endomyocardial Injection of Autologous Bone Marrow Cells to Treat Ischaemic Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01150175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*